Caldwell Sutter Capital, Inc. Viatris Inc Transaction History
Caldwell Sutter Capital, Inc.
- $218 Billion
- Q2 2025
A detailed history of Caldwell Sutter Capital, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Caldwell Sutter Capital, Inc. holds 2,963 shares of VTRS stock, worth $29,541. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,963
Previous 2,341
26.57%
Holding current value
$29,541
Previous $20.4 Million
29.73%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding VTRS
# of Institutions
1,129Shares Held
983MCall Options Held
7.62MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA145MShares$1.45 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$924 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD78.8MShares$785 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az66.4MShares$662 Million3.26% of portfolio
-
State Street Corp Boston, MA55.3MShares$551 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.1B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...